ImmunityBio, Inc. (IBRX)

ImmunityBio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4,274	3,352	2,030	2,417	1,448	373
Market Cap Growth	356.26%	65.15%	-16.04%	67.00%	288.28%	305.66%
Enterprise Value	4,998	3,968	2,646	2,746	1,627	335
PE Ratio	-	-5.75	-4.87	-6.97	-6.52	-2.36
PS Ratio	14151.95	5388.88	8456.42	2588.20	2392.63	169.31
PB Ratio	-5.23	-5.71	-4.54	-9.98	-12.08	3.09
P/FCF Ratio	-8.77	-8.44	-4.88	-8.41	-8.35	-2.39
P/OCF Ratio	-9.29	-9.14	-6.01	-8.81	-8.43	-2.45
EV/Sales Ratio	16550.26	6378.71	11025.55	2939.96	2689.30	152.25
EV/EBITDA Ratio	-9.87	-9.24	-8.05	-8.78	-8.27	-2.51
EV/EBIT Ratio	-9.36	-8.74	-7.50	-8.27	-7.58	-2.21
EV/FCF Ratio	-10.52	-9.99	-6.37	-9.55	-9.38	-2.15
Debt / Equity Ratio	-1.29	-1.50	-1.62	-2.67	-2.30	0.12
Debt / EBITDA Ratio	-2.03	-2.05	-2.20	-2.06	-1.40	-0.11
Debt / FCF Ratio	-2.17	-2.22	-1.74	-2.25	-1.59	-0.09
Quick Ratio	3.21	4.61	0.22	0.86	1.44	4.47
Current Ratio	3.64	5.05	0.28	0.91	1.64	4.82
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.01
Interest Coverage	-3.39	-3.51	-5.56	-22.35	-23.65	-25.67
Return on Equity (ROE)	103.00%	107.50%	102.30%	179.10%	-294.80%	-109.60%
Return on Assets (ROA)	-147.60%	-148.40%	-117.10%	-121.80%	-122.40%	-91.80%
Return on Capital (ROIC)	-170.57%	-122.73%	-127.08%	-81.86%	-141.83%	-115.94%
Earnings Yield	-14.06%	-17.40%	-20.53%	-14.35%	-15.33%	-42.32%
FCF Yield	-9.66%	-11.85%	-20.48%	-11.89%	-11.98%	-41.90%
Buyback Yield / Dilution	-57.06%	-27.19%	-2.74%	-3.23%	-2.93%	-362.93%
Total Shareholder Return	-57.06%	-27.19%	-2.74%	-3.23%	-2.93%	-362.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).